Micro-Coil stent aims to drain glaucoma pressure during cataract surgery

NCT ID NCT07698353

Ongoing Disease control Sponsor: Aquea Health, Inc. Source: ClinicalTrials.gov ↗

First seen Jul 13, 2026 · Last updated Jul 14, 2026 · Updated 1 time

Summary

This study tests a small, coiled stent designed to widen a natural drainage channel in the eye, helping fluid drain and lower pressure in people with open-angle glaucoma. Participants receive the stent in one eye at the same time as cataract surgery. The goal is to see if the stent safely reduces eye pressure by at least 20% without the need for glaucoma medications one year after surgery.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Aquea Zealix intracanalicular glaucoma micro-coil stent
What this could lead to: If successful, this stent could offer a new way to lower eye pressure in glaucoma patients during routine cataract surgery, potentially reducing the need for daily eye drops.
What could go wrong: This is a small early feasibility study with only 29 participants, so results may not apply to everyone. The stent is a device and carries surgical risks such as infection or device migration.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CATARACT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cataract open-angle glaucoma senile cataract

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CATARACT SENILE GLAUCOMA, OPEN-ANGLE

Contacts and locations

Show contact details

Locations

Panama Eye Center

Panama City, Provincia de Panamá, XFGH+9HQ, Panama

More trials for these conditions

Other studies related to the condition(s) this trial covers.